Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCHE | P06276 | 17/20 | 0.51 |
| ▸ | ACHE | P22303 | 17/20 | 0.51 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.47 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9312790 | 0.90 | BCHE (0.59) | BCHEACHEPTGS1PTGS2CYP1A2 | |
| SCHEMBL9250968 | 0.86 | HTT (0.44) | BCHEACHEMEN1HTTKMT2A | |
| SCHEMBL9254923 | 0.86 | BCHE (0.54) | BCHEACHEPTGS1PTGS2CYP1A2 | |
| SCHEMBL8542430 | 0.81 | PTGS1 (0.57) | BCHEACHEPTGS1PTGS2CYP1A2 | |
| SCHEMBL9313964 | 0.80 | BCHE (0.49) | BCHEACHEPTGS1PTGS2CYP1A2 | |
| SCHEMBL9257226 | 0.80 | PTGS1 (0.46) | BCHEACHEPTGS1PTGS2CYP1A2 | |
| SCHEMBL9256806 | 0.78 | PTGS1 (0.49) | BCHEACHEPTGS1PTGS2CYP1A2 | |
| SCHEMBL8538124 | 0.78 | PTGS1 (0.53) | BCHEACHEPTGS1PTGS2CYP1A2 | |
| SCHEMBL9265028 | 0.77 | PTGS1 (0.51) | BCHEACHEPTGS1PTGS2CYP1A2 | |
| SCHEMBL9314049 | 0.77 | BCHE (0.62) | BCHEACHEPTGS1PTGS2CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5395834-A | Antiarthritic agents or cardiovascular disorders | ADIR ET COMPAGNIE (FR) | 1995-03-07 | — | — | US | disclosed |
| US-5393775-A | Administering a (2-chromanyl)alkylcarboxylic acid for disorders connected with peroxidation processes | ADIR ET COMPAGNIE (FR) | 1995-02-28 | — | — | US | disclosed |
| EP-0587499-A1 | Benzopyran compounds, process for their preparation and their use as cell protectors | ADIR ET COMPAGNIE (FR) | 1994-03-16 | — | — | EP | disclosed |